All News

Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting

Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

The first One Young World - Novartis Caucus took place virtually on February 11, 2021.

Novartis Cosentyx gains EU label update for first-of-its-kind MAXIMISE data in axial manifestations of psoriatic arthritis

Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.

Learn More


This site uses cookies and analysis tools to improve the usability of the site. More information. |